Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Medtronic
Cerilliant
Federal Trade Commission
Express Scripts
Covington
Colorcon
UBS
Deloitte

Generated: August 21, 2018

DrugPatentWatch Database Preview

Mylan Technologies Company Profile

« Back to Dashboard

What is the competitive landscape for MYLAN TECHNOLOGIES, and what generic and branded alternatives to MYLAN TECHNOLOGIES drugs are available?

MYLAN TECHNOLOGIES has twelve approved drugs.



Drugs and US Patents for Mylan Technologies

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Technologies ESTRADIOL estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 201675-002 Dec 19, 2014 AB1 RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Technologies NITROGLYCERIN nitroglycerin FILM, EXTENDED RELEASE;TRANSDERMAL 074559-002 Aug 30, 1996 AB2 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Technologies ESTRADIOL estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 206685-004 Aug 15, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Technologies BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE buprenorphine hydrochloride; naloxone hydrochloride FILM;BUCCAL, SUBLINGUAL 207607-001 Jun 14, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Technologies FENTANYL-75 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 076258-003 Jan 28, 2005 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Medtronic
Fuji
Argus Health
Cipla
McKesson
Covington
Deloitte
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.